ArticleSensors (Basel, Switzerland)2025
Optimized Machine Learning for the Early Detection of Polycystic Ovary Syndrome in Women.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Machine learning and deep learning for diagnosis of Polyendocrine Metabolic Ovarian Syndrome: systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
- Clustering of non-invasive biomarkers to distinguish phenotype-related response differences in women with PCOS after the 16-week Nordic interval training intervention: A prospective cohort study.Journal of exercise science and fitness · 2026Article
- A comparative study of quantum-inspired PSO and EA with their binary variants for heart disease classification.Scientific reports · 2026Article
- Diagnostic performance of deep learning models on ultrasound images for distinguishing benign from malignant ovarian cysts.Journal of ovarian research · 2026Article
- Article
- AI-quantum framework for accurate infertility risk classification in PCOS patients using EHR data.Frontiers in artificial intelligence · 2026Article
- Balancing metabolic optimization and reproductive safety in Polycystic Ovary Syndrome: a Bayesian-informed framework for GLP-1 receptor agonists.Frontiers in nutrition · 2026Review
- A machine learning approach for non-invasive PCOS diagnosis from ultrasound and clinical features.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic ovary syndrome (PCOS) is a medical condition that impacts millions of women worldwide; however, due to a lack of public awareness, as well as the expensive testing involved in the identification of PCOS, 70% of cases go undiagnosed. Therefore, the primary objective of this study is to design an expert machine learning (ML) model for the early diagnosis of PCOS based on initial symptoms and health indicators; two datasets were amalgamated and preprocessed to accomplish this goal, resulting in a new symptomatic dataset with 12 attributes. An ensemble learning (EL) model, with seven base classifiers, and a deep learning (DL) model, as the meta-level classifier, are proposed. The hyperparameters of the EL model were optimized through the nature-inspired walrus optimization (WaO), cuckoo search optimization (CSO), and random search optimization (RSO) algorithms, leading to the WaOEL, CSOEL, and RSOEL models, respectively. The results obtained prove the supremacy of the designed WaOEL model over the other models, with a PCOS prediction accuracy of 92.8% and an area under the receiver operating characteristic curve (AUC) of 0.93; moreover, feature importance analysis, presented with random forest (RF) and Shapley additive values (SHAP) for positive PCOS predictions, highlights crucial clinical insights and the need for early intervention. Our findings suggest that patients with features related to obesity and high cholesterol are more likely to be diagnosed as PCOS positive. Most importantly, it is inferred from this study that early PCOS identification without expensive tests is possible with the proposed WaOEL, which helps clinicians and patients make better informed decisions, identify comorbidities, and reduce the harmful long-term effects of PCOS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.